Science Explorer Back to mapMap
Discussion
Researcher · Ariadne Diagnostics (United States) · United States

Anna Kohlmann

Anna Kohlmann publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Cancer, Hypoxia, and Metabolism.

ORCID 0000-0003-1303-654X OpenAlex
World rank
#1,347,206
of 7,710,434 ranked researchers
Rank in United States
#427,098
of 1,627,098
Works
41
Citations
1.1k
Citations per work
26.1
h-index
13
i10-index 14Top 59% in Molecular Biology
Anna Kohlmann

What does Anna Kohlmann research?

Anna Kohlmann's work is mostly in Biochemistry, Genetics and Molecular Biology (43%), Medicine (32%), Computer Science (7%).

Life Sciences: 18 works · 43.4% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 43.4% of their workMolecular Biology: 15 works · 36.7% of their workCancer Research: 3 works · 6.7% of their workHealth Sciences: 13 works · 31.7% of their workMedicine: 13 works · 31.7% of their workOncology: 8 works · 20.0% of their workPulmonary and Respiratory Medicine: 5 works · 11.7% of their workEverything else: 8 works · 18.3% of their workPhysical Sciences: 3 works · 6.6% of their workComputer Science: 3 works · 6.6% of their workArtificial Intelligence: 1 works · 3.3% of their workComputational Theory and Mathematics: 1 works · 3.3% of their workTHEIR WORKAnna Kohlmann41works
Life Sciences43%Physical Sciences7%Health Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1843.4%
    1. Medicine1331.7%
  3. Everything else818.3%
    1. Computer Science36.6%
  1. 1Molecular Biology37% of their works
  2. 2Oncology20% of their works
  3. 3Pulmonary and Respiratory Medicine12% of their works
  4. 4Cancer Research7% of their works
  5. 5Computational Theory and Mathematics3% of their works
  6. 6Artificial Intelligence3% of their works

Research topics

Which keywords describe Anna Kohlmann's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Tumor Microenvironment, ALK Inhibitors, Cancer Therapy, EGFR Mutations and Tumor Hypoxia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Clinical Trials92 topics
  2. Targeted Therapy92 topics
  3. Chemotherapy62 topics
  4. Tumor Microenvironment62 topics
  5. ALK Inhibitors51 topic
  6. Cancer Therapy52 topics
  7. EGFR Mutations51 topic
  8. Tumor Hypoxia52 topics
  9. Genomic Profiles41 topic
  10. Inhibitors42 topics
  11. Small-Cell Lung Cancer41 topic
  12. Fibroblast Activation Protein31 topic
  13. HIF-131 topic
  14. Immunosuppression31 topic
  15. Warburg Effect31 topic
  16. Activators21 topic
  17. Calcineurin21 topic
  18. Carbonic Anhydrases21 topic
  19. DNA21 topic
  20. NFAT21 topic
  21. Signaling21 topic
  22. Topoisomerases21 topic
  23. mTOR21 topic

Where does Anna Kohlmann work?

Anna Kohlmann's main affiliation in the publication record is Ariadne Diagnostics (United States), United States.

How many publications and citations does Anna Kohlmann have?

OpenAlex counts 41 works and 1,069 citations for Anna Kohlmann, an h-index of 13, ranking #1,347,206 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anna Kohlmann. Posts are plain text and can be reported.